🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04302220
Active, not recruiting Observational

Myopic Optic Neuropathy in Chinese High Myopia Population

NCT04302220 · tracked via the Priya Life Science China tracker
Sponsor
Sun Yat-sen University
Phase
Observational
Started
2019-06-06
Last updated
2024-12-09

Condition(s) studied

Eye Diseases

Study summary

This study intends to establish a registry cohort to enroll patients with high myopia to study the natural course of myopic optic neuropathy in Chinese adult population.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria * Age ≥18 years * Equivalent spherical ≤-6D or axial length ≥26.5mm * Best corrected visual acuity ≥ 6/12 Exclusion Criteria * Unwilling or unable to give consent, or unable to return for scheduled protocol visits. * Glaucoma secondary to penetrating keratoplasty, trauma, steroids, retinal disease/surgery, or neovascular disease. * Obvious corneal and iris lesions, or severe cataracts interfering with fundus examinations, VF test or monophthalmia. * Need for ocular surgery/laser or anticipated need for cataract surgery during the study period. * Other serious systemic diseasesf (i.e. hypertension, heart disease, diabetes, or rheumatic immune system diseases); * Pregnant or nursing women

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zhongshan Ophthalmic Center Guangzhou Guangdong

More Sun Yat-sen University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04302220 on ClinicalTrials.gov ↗ ← All trials in China